Oocyte Gene Figla May Steer Ovarian Reserve Formation Through Ywhab, Mouse Study Suggests

Every woman is born with all the eggs she will ever have. The finite pool of primordial follicles that constitutes the ovarian reserve is assembled in the days around birth in mice, and disturbances during this narrow developmental window can echo across a lifetime of fertility, sometimes manifesting decades later as premature ovarian insufficiency, a condition in which the ovaries cease functioning before the age of forty. Despite the clinical weight of this process, the molecular choreography that transforms nests of naked oocytes into individually wrapped primordial follicles remains only partially mapped. A new study published in Reproductive Sciences by Le Yang, Linshuang Li, Lin Shen and Hanwang Zhang adds a fresh piece to that puzzle, pointing to a gene called Ywhab as a candidate downstream target of the oocyte-specific transcription factor Figla during the establishment of the ovarian reserve.

Figla, short for factor in the germline alpha, is a basic helix-loop-helix transcription factor expressed almost exclusively in oocytes. It first earned its reputation in the late 1990s, when researchers showed that it coordinates the expression of the zona pellucida genes, the family of genes encoding the protective glycoprotein shell that surrounds every egg. Later work proved that Figla is not merely a structural coordinator but an indispensable architect of folliculogenesis itself: mice lacking Figla fail to form primordial follicles, and their oocytes are progressively lost after birth. In humans, mutations in FIGLA have been identified in patients with premature ovarian failure, and increased FIGLA expression is associated with the moment primordial follicles begin to form in the human fetal ovary. What has remained elusive, however, is a comprehensive picture of which genes Figla actually controls to accomplish these feats.

To close that gap, the team generated a Figla knockout mouse model and examined what happens to ovarian development when the transcription factor is removed. Their timing analysis showed that Figla is highly expressed in late embryonic and early postnatal ovaries, precisely the period when primordial follicle assembly takes place. When Figla was deleted, the disruption was concentrated in this perinatal window: the assembly of primordial follicles was primarily impaired, and the knockout ovaries suffered progressive oocyte loss as development proceeded. This phenotype is consistent with the known biology of the gene but, crucially, the researchers did not stop at confirming the knockout effect. They set out to find what Figla might be acting upon.

The search for downstream targets relied on chromatin immunoprecipitation sequencing, or ChIP-seq, a technique that allows researchers to map, across the entire genome, the DNA regions where a given protein physically binds. By pulling down FIGLA-associated chromatin from ovarian tissue and sequencing the captured fragments, the team identified the genomic sites the transcription factor occupies in vivo. Motif analysis of these binding regions then asked whether the sequences showed the characteristic signature of FIGLA recognition, and promoter activity assays tested whether candidate regulatory regions could actually drive gene expression in a FIGLA-dependent manner. Together, these three lines of evidence converged on one particularly interesting candidate: Ywhab, the gene encoding YWHA-beta, one member of the 14-3-3 family of phosphoserine-binding proteins.

The 14-3-3 proteins are a family of highly conserved scaffolding molecules that recognize and bind specific phosphorylated motifs on other proteins, thereby acting as molecular adapters that relay signals, control protein localization and modulate enzyme activity. YWHA-beta, the isoform encoded by Ywhab, has well-documented roles in two signaling circuits that are directly relevant to cell survival and proliferation. The first involves the RAF kinases, where 14-3-3 dimers serve as essential cofactors for RAF kinase activity, a critical node at the top of the mitogen-activated protein kinase cascade that culminates in the phosphorylation of ERK, or extracellular signal-regulated kinase. The second involves BAD, a pro-apoptotic member of the BCL-2 family. When BAD is phosphorylated at a specific serine residue, 14-3-3 proteins bind it and sequester it away from the mitochondria, preventing it from triggering the apoptotic machinery. In this way, 14-3-3 proteins function as a molecular switch that tips the balance between cell survival and programmed cell death.

Armed with the ChIP-seq, motif and promoter data, the researchers moved into functional testing. They used KGN cells, a human granulosa-like tumor cell line that expresses a functional follicle-stimulating hormone receptor and has become a standard model for studying granulosa cell biology. When the team overexpressed Figla in these cells, Ywhab expression rose, and the cells displayed measurably greater growth activity and migration. Alongside these behavioral changes, the overexpression coincided with increased ERK phosphorylation and alterations in the levels of apoptosis-related markers, including BAD, BCL-2 and BAX, the canonical trio that governs mitochondrial apoptosis. The picture that emerged was of Figla pushing granulosa cells toward a more proliferative, more migratory and more survival-oriented state, with Ywhab sitting plausibly in the middle of that response.

The decisive experiment came next. If Ywhab were truly mediating Figla’s effects, then removing Ywhab should blunt those effects even when Figla is abundant. That is exactly what the team observed: when they knocked down Ywhab in the Figla-overexpressing KGN cells, the enhanced growth activity, the increased migration, the elevated ERK phosphorylation and the changes in the BAD, BCL-2 and BAX markers were all attenuated. In other words, Ywhab was not merely a passive readout of Figla activity but appeared to be functionally required for the cellular consequences of that activity, at least in this cell culture system.

To connect the cell culture findings back to intact ovarian physiology, the researchers performed Western blot analysis on ovarian tissue from their mouse models. In the Figla-deficient ovaries, they found a reduced ratio of phosphorylated ERK to total ERK, indicating dampened activity of the MAPK signaling pathway, together with an increased ratio of phosphorylated BAD to total BAD. The direction of these changes in the knockout tissue mirrors what one would predict if Figla normally drives Ywhab-dependent signaling: loss of Figla weakens the pro-survival, pro-proliferative signaling axis, and the apoptotic balance shifts in a way that is consistent with the progressive oocyte loss seen in the knockout animals. The convergence of the in vitro and in vivo data strengthens the case that the Figla-Ywhab relationship is not an artifact of the cell line.

The significance of this work lies in how it links two levels of biology that are usually studied separately. On one level, Figla is a transcription factor operating inside the oocyte, orchestrating the gene expression program that allows follicles to assemble. On another level, the ERK pathway and the BCL-2 family are signaling systems that govern the behavior of granulosa cells and the survival of the oocyte-granulosa unit. By proposing Ywhab as a bridge between these levels, the study suggests a mechanism through which an oocyte-specific transcription factor could influence the signaling environment of the surrounding somatic cells during the critical perinatal period. Given that programmed cell death and germ cell loss are recognized features of primordial follicle assembly, and that ERK signaling in granulosa cells has been shown in earlier work to be essential for female fertility, a transcriptional link connecting these processes is exactly the kind of finding the field has been looking for.

The authors themselves are careful about the limits of the study. Ywhab is presented as a candidate downstream gene, not a definitively validated direct target, and the functional experiments were conducted in a granulosa cell line rather than in oocytes or intact follicles. The knockout phenotype, while striking, does not by itself prove that every aspect of it flows through Ywhab. Extending these findings to the broader process of ovarian reserve establishment, or to premature ovarian insufficiency in patients, will require further validation, ideally including direct demonstration of FIGLA binding to the Ywhab promoter in oocytes, genetic rescue experiments and analysis in human tissue. Nevertheless, the study provides a concrete and testable hypothesis: that the lifespan-defining act of assembling the ovarian reserve depends, in part, on a transcription factor in the egg switching on a signaling adaptor in its cellular neighborhood. If that hypothesis holds up, genes in the Figla-Ywhab-ERK axis could become markers for ovarian reserve quality and, one day, targets for interventions aimed at protecting the follicle pool in women at risk of premature ovarian insufficiency.

Subject of Research: The role of the transcription factor Figla and its candidate downstream target Ywhab in primordial follicle formation and ovarian reserve establishment

Article Title: Identification of Ywhab as a Candidate Downstream Target of Figla During Ovarian Reserve Establishment

Article References: Yang, L., Li, L., Shen, L., & Zhang, H. (2026). Identification of Ywhab as a Candidate Downstream Target of Figla During Ovarian Reserve Establishment. Reproductive Sciences. https://doi.org/10.1007/s43032-026-02173-w

Image Credits: AI Generated

DOI: 10.1007/s43032-026-02173-w

Keywords: Figla, Ywhab, ovarian reserve, primordial follicle, oocyte, granulosa cells, transcription factor, ERK signaling, apoptosis, premature ovarian insufficiency, ChIP-seq, 14-3-3 proteins